These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23294005)

  • 1. The development of models for the evaluation of pulmonary drug disposition.
    Liu X; Jin L; Upham JW; Roberts MS
    Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):487-505. PubMed ID: 23294005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
    Sakagami M
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals.
    Nahar K; Gupta N; Gauvin R; Absar S; Patel B; Gupta V; Khademhosseini A; Ahsan F
    Eur J Pharm Sci; 2013 Aug; 49(5):805-18. PubMed ID: 23797056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemistry, physiology and drug metabolism--implications regarding the role of the lungs in drug disposition.
    Roth RA
    Clin Physiol Biochem; 1985; 3(2-3):66-79. PubMed ID: 3891197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling of drug disposition kinetics in in vitro intestinal absorption cell models.
    Heikkinen AT; Korjamo T; Mönkkönen J
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):180-8. PubMed ID: 20030630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment methods of inhaled aerosols: technical aspects and applications.
    Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H
    Expert Opin Drug Deliv; 2009 Sep; 6(9):941-59. PubMed ID: 19637979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of pulmonary insulin in the in vitro isolated perfused rat lung: implications of metabolism and regional deposition.
    Pang Y; Sakagami M; Byron PR
    Eur J Pharm Sci; 2005; 25(4-5):369-78. PubMed ID: 15979534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive lung-targeted drug delivery systems via intravenous administration.
    Wei Y; Zhao L
    Pharm Dev Technol; 2014 Mar; 19(2):129-36. PubMed ID: 23336716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
    Byron PR; Hindle M; Lange CF; Longest PW; McRobbie D; Oldham MJ; Olsson B; Thiel CG; Wachtel H; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S59-69. PubMed ID: 21133801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based in vitro models for predicting drug permeability.
    Sarmento B; Andrade F; da Silva SB; Rodrigues F; das Neves J; Ferreira D
    Expert Opin Drug Metab Toxicol; 2012 May; 8(5):607-21. PubMed ID: 22424145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered disposition of drugs in acute renal failure rat models: drug development strategies and perspectives.
    Srinivas NR
    Arzneimittelforschung; 2010; 60(12):731-48. PubMed ID: 21265465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The particle has landed--characterizing the fate of inhaled pharmaceuticals.
    Patton JS; Brain JD; Davies LA; Fiegel J; Gumbleton M; Kim KJ; Sakagami M; Vanbever R; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S71-87. PubMed ID: 21133802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo animal models for drug delivery across the lung mucosal barrier.
    Cryan SA; Sivadas N; Garcia-Contreras L
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1133-51. PubMed ID: 17900750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary absorption - estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysis.
    Eriksson J; Sjögren E; Thörn H; Rubin K; Bäckman P; Lennernäs H
    Eur J Pharm Biopharm; 2018 Mar; 124():1-12. PubMed ID: 29191716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption.
    Harwood MD; Neuhoff S; Carlson GL; Warhurst G; Rostami-Hodjegan A
    Biopharm Drug Dispos; 2013 Jan; 34(1):2-28. PubMed ID: 22927116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary drug delivery: medicines for inhalation.
    Henning A; Hein S; Schneider M; Bur M; Lehr CM
    Handb Exp Pharmacol; 2010; (197):171-92. PubMed ID: 20217530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of absorption and elimination of drugs administered by inhalation.
    Ibrahim M; Garcia-Contreras L
    Ther Deliv; 2013 Aug; 4(8):1027-45. PubMed ID: 23919477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and toxicological implications of short-term studies in animals of pharmaceutical aerosol delivery to the lungs: relevance to humans.
    Hickey AJ; Garcia-Contreras L
    Crit Rev Ther Drug Carrier Syst; 2001; 18(4):387-431. PubMed ID: 11605897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical perspectives on pulmonary systemic and macromolecular delivery.
    Scheuch G; Kohlhaeufl MJ; Brand P; Siekmeier R
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):996-1008. PubMed ID: 16996638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fundamentals and Applications of Isolated Perfused Lung (IPL) Model in the Development of Pulmonary Drug Delivery.
    Mireskandari K; Ardakani YH; Moghadam ES; Ketabchi F; Rouini M
    Curr Drug Deliv; 2023; 20(10):1425-1440. PubMed ID: 36017864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.